GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹428 Cr | ₹542 Cr | ₹419 Cr | ₹1,066 Cr | ₹921 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹428 Cr |
| Mar2025 | ₹542 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹1,066 Cr |
| Mar2022 | ₹921 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹428 Cr | -21.05 | |
| Mar2025 | ₹542 Cr | 29.25 | |
| Mar2024 | ₹419 Cr | -60.66 | |
| Mar2023 | ₹1,066 Cr | 15.71 | |
| Mar2022 | ₹921 Cr | - | |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹70,263.6 Cr | 4% | 11.5% | 28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 4% |
11.5% |
28.7% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses